Finding a cure now...so our daughters won't have to.

Study: Tamoxifen Cuts Second Cancer Risk in BRCA Carriers

Posted By on September 16th, 2013 at 8:56 am | 0 comments.

Tamoxifen for PL New research shows that the drug Tamoxifen can greatly reduce the risk of a second breast cancer diagnosis in women who carry the BRCA1 or BRCA2 genes.  Women with the “breast cancer genes” are not often offered Tamoxifen as part of a treatment plan.  These findings could change that.

Investigators at the Peter MacCallum Cancer Centre in Australia studied thousands of women with the BRCA1 and BRCA2 genes over a span of 8 years.  During that time, women with the BRCA1 mutation were 63 percent less likely to develop a second cancer after taking Tamoxifen and women with the BRCA2 gene had a 67 percent lower risk with the drug.

To read more on the study, click here.

 

Leave a Reply